NACDS’ Congressional statement keys on lowering patients’ costs at pharmacy counter, reducing overall healthcare costs, and fostering pharmacy viability by preventing below-cost reimbursement.
Morning Consult today published an opinion piece by the NACDS entitled “DIR Fee Reform: Lining Up Another Win for Patients on Drug Costs.”
NACDS today submitted a statement to the U.S. House of Representatives Committee on Ways and Means for the hearing titled “The Cost of Rising Prescription Drug Prices.”
NACDS and the National Community Pharmacists Association (NCPA) today lauded 24 patient and consumer groups for advocating for pharmacy direct and indirect remuneration (DIR) fee reform.
NACDS and the National Community Pharmacists Association (NCPA) today praised a bipartisan Senate letter to Health and Human Services Secretary Alex Azar.
Patient advocacy groups and allies—including NACDS member companies, state associations and others—have joined together in urging HHS to implement DIR reform.
Each NACDS member company has a powerful opportunity to submit official comments to the Centers for Medicare & Medicaid Services (CMS) in support of direct and indirect remuneration (DIR) fee reform concepts described in […]
NACDS, WSPA, and NCPA applaud action by the federal Centers for Medicare & Medicaid Services (CMS) to reject Washington State’s below-cost and lowest-in-the-nation Medicaid pharmacy dispensing fees.
NACDS expressed support for, and provided further input, on CMS’ proposed rule, which involves issues including direct and indirect remuneration fees; e-prescribing; medication therapy management; opioid abuse; and fostering pharmacy access.
